Press Releases
February 2, 2010 - Nuvilex, Inc. Announces that Legacy Biotechnologies' Reme-Flu with Syn-X9 Formulation Receives FDA National Drug Code Number.
December 18, 2009 - Nuvilex To Host A Fiscal Year 2010 Second Quarter Financial Results Call on December 22.
December 11, 2009 - Nuvilex' Last Shot Hangover Remedy Changes Its Name to Cinnsational and Teams with Leading Marketing Firm Talent Resources.
December 7, 2009 - Nuvilex Reports Clementine Art Estimates their Market Opportunity for its All-Natural Art Products Manufactured with Nuvilex Inks to be $65 Million.
November 20, 2009 - Nuvilex Signs Production Agreement with Clementine Art, Inc.
November 6, 2009 - Change in Directors or Principal Officers
October 22, 2009 - Nuvilex, Inc. Reports that Phase 2 Microplot Trials of Oraphyte Confirm it To Be a Commercially Viable All-Natural Nematocide
October 1, 2009 - Nuvilex, Inc. Announces Unregistered Sale of Equity Securities
September 21, 2009 - Nuvilex, Inc. Announces that Reme-Flu™ will Incorporate Proprietary Syn-X9™ Delivery Technology into its Product Formulation
September 15, 2009 - Nuvilex, Inc. Announces that Reme-Flu™ will be Available for Sale on Top-Rated Internet Website
September 14, 2009 - Nuvilex, Inc. Announces Positive Oraphyte™ Microplot Results
September 11, 2009 - Nuvilex, Inc. Announces Reme-Flu™ as Trade Name for All-Natural Flu Remedy Formula
September 9, 2009 - Nuvilex, Inc. Finalizes Joint Venture Agreement for the Development of Broad Spectrum All-Natural Flu Remedies
September 3, 2009 - The KonLin Letter Issues Featured Stock Update on Nuvilex, Inc. in its September 2009 Edition
September 2, 2009 - Nuvilex, Inc. Sets Times and Locations for Upcoming Shareholder Meetings
August 27, 2009 - Nuvilex Introduces Last Shot Hangover Remedy™ Video
August 26, 2009 - Nuvilex Launches Last Shot Hangover Remedy™ Web Site
August 25, 2009 - Nuvilex to Issue Positive Shareholder Newsletter
July 15, 2009 - Nuvilex Completes First Sale of Last Shot Hangover Remedy™
July 8, 2009 - Nuvilex, Inc. Announces Business Update Conference Call
June 24, 2009 - Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health
June 17, 2009 - Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
June 5, 2009 - Nuvilex Offers Free Cinnergen
Samples in Response to Spike in Consumer Interest
June 2, 2009 - Nuvilex Declares Stock Dividend
June 1, 2009 - Hangover Remedy and Removable Tattoo Ink: Biotech in Action
June 1, 2009 - Nuvilex Launches Video Marketing Campaign
May 28, 2009 - Nuvilex’ Gets Update from CK41 on purEffect™ Launch Plan
May 27, 2009 - Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink the World’s First Permanent, But Easier to Remove
Tattoo Ink -- in Australia and New Zealand
May 27, 2009 - Time Magazine Reports on Infinitink Tattoo Ink from Nuvilex
May 19, 2009 - Nuvilex, Inc. Announces Monthly Investor Conference Call
April 9, 2009 - Nuvilex, Inc.’s Marketing Partner, CK41 to Launch purEffect™ in May
April 9, 2009 - Nuvilex, Inc. Announces Investor Conference Call and Open House
April 8, 2009 - Nuvilex, Inc. Announces New Pricing for Cinnergen and
Launch of dLife Advertising and Promotion Campaign
March 18, 2009 - eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc.,
Reflecting New Strategic Direction of Company
|
